Iradimed (IRMD) Cash from Investing Activities Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.94% |
| Dec 31, 2025 | -27.62% |
| Sep 30, 2025 | -62.81% |
| Jun 30, 2025 | -63.91% |
| Mar 31, 2025 | -76.24% |
| Dec 31, 2024 | -39.42% |
| Sep 30, 2024 | -37.58% |
| Jun 30, 2024 | -41.85% |
| Mar 31, 2024 | -23.38% |
| Dec 31, 2023 | -20.96% |
| Sep 30, 2023 | -21.83% |
| Jun 30, 2023 | 1.69% |
| Mar 31, 2023 | -101.20% |
| Dec 31, 2022 | 20.82% |
| Sep 30, 2022 | -72.37% |
| Jun 30, 2022 | -33.36% |
| Mar 31, 2022 | -47.07% |
| Dec 31, 2021 | 19.48% |
| Sep 30, 2021 | -32.44% |
| Jun 30, 2021 | 28.23% |
| Mar 31, 2021 | 28.29% |
| Dec 31, 2020 | 15.69% |
| Sep 30, 2020 | -6.89% |
| Jun 30, 2020 | 39.76% |
| Mar 31, 2020 | -41.17% |
| Dec 31, 2019 | 16.18% |
| Sep 30, 2019 | 109.73% |
| Jun 30, 2019 | 28.29% |
| Mar 31, 2019 | 131.23% |
| Dec 31, 2018 | 88.07% |
| Sep 30, 2018 | 54.84% |